How Much Health Spending Comes From Domestic Government Sources?

Government financing plays a very different role across health systems. Among the 194 country or area observations dated 2023, the unweighted median domestic government share of current health expenditure is 56.8% and the simple mean is 52.7%. Eighty-seven observations are at 60% or above, while 23 are below 20%. The Republic of Korea is at 58.6%, slightly above the median. The spread makes the financing mix more informative than a single headline average.

The WHO indicator used here is Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE). It asks what share of current health spending is financed from domestic general government sources. Those sources include transfers from government domestic revenues for health and social health insurance contributions. The measure therefore describes the government-financed share of health spending, not the share of the entire government budget allocated to health.

What the indicator measures — and what it should not be confused with

WHO defines the indicator as the share of current health expenditure funded from general government domestic sources. The formal measurement adds transfers from government domestic revenue allocated to health and social insurance contributions, then divides by current health expenditure. The WHO indicator metadata explains that the measure is intended to show the role of domestic government sources relative to domestic private and external financing.

This is different from “health spending as a share of total government expenditure.” The denominator here is current health expenditure. A value of 70% means that about 70% of current health spending in that observation year was financed from domestic government sources. It does not mean that 70% of the government budget went to health. WHO publishes a separate GGHE-D-to-general-government-expenditure indicator for that question.

The financing share also says nothing about who owns the hospitals or clinics delivering care. A system can finance care through government revenue or social insurance while paying public, nonprofit or private providers. Financing and provision are related institutional choices, but this percentage measures the source of money rather than the ownership structure of providers.

The 2023 median is 56.8%, with 87 observations at 60% or more

Using only the 194 observations dated 2023, the unweighted median is about 56.8% and the simple mean is about 52.7%. The mean sits below the median because the lower tail extends much farther toward zero than the upper tail can extend beyond 100. These are descriptive country-level statistics: each row receives the same weight, so they are not population-weighted or expenditure-weighted world shares.

The distribution contains four observations below 10%, 19 from 10% to under 20%, 12 from 20% to under 30%, 22 from 30% to under 40%, and 25 from 40% to under 50%. Another 25 fall from 50% to under 60%, 34 from 60% to under 70%, 33 from 70% to under 80%, 19 from 80% to under 90%, and one is at 90% or above. In total, 87 of 194 are at least 60%, while 23 are below 20%.

Brunei has the highest 2023 share, while several Nordic and Gulf states also rank high

Brunei Darussalam records the highest 2023 value at 92.5%. Kuwait follows at 88.5%, the Cook Islands at 87.7%, San Marino at 86.9%, Luxembourg at 86.6%, and Norway and Sweden at about 86.1% each. Monaco is at 85.7%, Oman 85.3%, Japan 84.8%, Czechia 84.3%, and Croatia 84.0%. These percentages rank the financing composition of current health expenditure, not total government spending or the absolute amount of money spent on health.

The upper end spans very different health-system arrangements. Nordic countries such as Norway, Sweden, Denmark and Finland are all above 80%, but so are Kuwait, Oman and Qatar in the Gulf, as well as Japan in East Asia. Similar financing shares do not establish that these countries use the same tax, insurance or provider arrangements. The indicator should be treated as one structural measure rather than a health-system typology.

Afghanistan, South Sudan, Yemen and Haiti are below 10%

At the lower end, Afghanistan is at 1.7%, South Sudan 4.3%, Yemen 8.4%, and Haiti 9.3%. Liberia is at 10.0%, Guinea-Bissau 10.6%, Myanmar 11.1%, Togo 11.1%, Malawi 12.8%, Comoros 12.9%, Nigeria 14.1%, and Somalia 14.2%. These are very different financing mixes from the countries at the top of the distribution.

A low value should not be read as a statement that a country spends little on health in absolute terms, nor does it by itself establish weak government commitment. The remainder of current health expenditure can be financed from domestic private sources or external sources, and the total size of current health expenditure also varies widely. Per-capita spending, health expenditure as a share of GDP, and the government-budget share answer different questions.

Europe has many high values, but the region is not uniform

Much of Europe appears in the upper bands. Sweden and Norway are both about 86.1%, Denmark is 83.3%, Finland 81.1%, Germany 79.1%, Poland 77.1%, Romania 75.9%, Spain 73.2%, and Italy 73.1%. France is lower at 67.7%, while Greece is 50.6%. A regional label therefore hides meaningful variation in how current health expenditure is financed.

The Middle East and Gulf also show large internal differences. Kuwait is at 88.5%, Oman 85.3%, Qatar 83.0%, and Saudi Arabia 77.8%. The United Arab Emirates is at 66.8% and Bahrain 59.3%, while Iran is 46.7%, Iraq 46.0%, Jordan 45.0%, and Yemen only 8.4%. Geographic proximity does not imply a common government-financing share.

Asia and the Americas span almost the full range of the indicator

Across Asia, Japan is at 84.8% and Thailand at 77.9%, while the Republic of Korea is 58.6%, China 57.1%, Indonesia 53.6%, Malaysia 50.0%, Viet Nam 44.3%, the Philippines 42.4%, India 39.0%, and Pakistan 35.7%. Bangladesh is much lower at 14.5% and Afghanistan at 1.7%. Income, geography and population size alone cannot substitute for checking the financing indicator directly.

The Americas are similarly varied. Cuba is at 83.4%, Colombia 70.3%, Costa Rica 67.2%, the Dominican Republic 64.1%, and Argentina 60.2%. Chile is at 51.6%, Mexico 48.6%, and Brazil 44.1%, while Haiti is only 9.3%. The map therefore shows financing structure rather than a simple continental gradient.

Sub-Saharan Africa includes both very low and relatively high government shares

A number of Sub-Saharan African countries are in the lower bands: Nigeria is 14.1%, Malawi 12.8%, Ethiopia 21.9%, Uganda 21.8%, Mozambique 26.5%, Tanzania 31.7%, Zimbabwe 32.4%, and Zambia 40.7%. Kenya is at 44.9% and Rwanda 47.0%. At the same time, Ghana is at 63.2%, South Africa 61.6%, and Botswana 75.5%. Treating the whole region as a single financing pattern would miss these differences.

The geographic clustering visible on a choropleth is descriptive, not causal. Tax systems, social insurance, household payments, private insurance, donor funding and the overall level of health spending differ across countries. This single financing-share series cannot identify which institutional factor caused a country to sit in a particular color band.

Korea is at 58.6%, slightly above the 2023 median

The Republic of Korea reports 58.6% in 2023. In the same dataset, Japan is at 84.8%, the United Kingdom 81.8%, Germany 79.1%, Australia 73.7%, Canada 70.3%, France 67.7%, South Africa 61.6%, China 57.1%, the United States 54.0%, Mexico 48.6%, Brazil 44.1%, and India 39.0%. This comparison is about the financing mix of current health expenditure, not the overall level or quality of care.

Korea’s 58.6% should not be simplified into “the government directly paid 58.6% of every patient’s bill.” WHO’s domestic general government category includes social health insurance contributions as well as transfers from government domestic revenue. Household out-of-pocket spending is tracked through a separate indicator and should be used when the question is how much patients pay directly.

Ukraine is the only latest observation that is not from 2023

The latest-value table contains 195 country or area observations. A total of 194 are dated 2023. Ukraine is the only exception, with a latest retained observation of 52.1% in 2021. The world map keeps that latest value for geographic completeness and marks Ukraine with hatching, while the 2023 mean, median, band counts and rankings exclude it.

This separation keeps two useful questions distinct. A latest-value map asks what the most recent reported level is for each place. A synchronized ranking asks how places compare in the same year. Relabeling Ukraine’s 2021 value as 2023 would create false precision, so the older observation is used only where the latest-value framing is explicit.

A high government share is not a performance score

The indicator measures where the financing comes from. It does not directly measure access to care, waiting times, quality, health outcomes, life expectancy, efficiency or whether total resources are adequate. Countries with similarly high government shares can still differ greatly in service coverage and financial protection.

The reverse is also true. A low government share is not automatically evidence of a poor health system. Domestic private prepayment, employer funding, household payments or external funding may play larger roles, and institutional arrangements vary. To study household exposure, out-of-pocket spending and catastrophic health expenditure are more direct measures. To study resource levels, per-capita current health expenditure is more appropriate. To study government budget priority, the health share of total government expenditure should be used.

Data source and mapping method

The statistical source is WHO Global Health Observatory indicator GHED_GGHE-DCHE_SHA2011. The WHO indicator page defines it as the share of current health expenditure funded from domestic general government sources and gives the financing-source formula using government domestic revenue transfers and social insurance contributions. The broader health-accounts series can be explored through the WHO Global Health Expenditure Database.

The latest-value table contains 195 country or area rows: 194 from 2023 and Ukraine from 2021. The choropleth uses all 195 latest observations, while the mean, median, distribution chart and rankings use only the 194 rows dated 2023. Missing observations are not converted to zero and the 2021 Ukraine value is never relabeled as a 2023 observation.

ISO-3 codes are joined to a simplified global boundary layer for the map. Small island states and separately reported areas can be present in the statistical table without appearing as visible polygons at this scale. The color classes are intended to show large differences in financing structure rather than imply that small decimal-point differences represent meaningful health-system rankings.

Frequently Asked Questions

Related Articles

These Green Map articles provide additional country-level health and living-condition indicators or survey guidance that can help place the financing map in a broader public-health context.

• Global Clean Cooking Access Map – Country Patterns in 2023
• Rural Cooking Energy Gap in 2023 – Global Map
• Tanzania 2022 TDHS-MIS Guide – Demographic, Health and Malaria Survey